These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 9179358)
21. Screening of the plants of the family Loranthaceae for toxic proteins. II. Samuelsson G Acta Pharm Suec; 1969 Oct; 6(4):441-6. PubMed ID: 5377780 [No Abstract] [Full Text] [Related]
23. [Unconventional cancer therapy on trial. Mistletoe preparations: only effective in the test tube?. Interview by Elke Runge]. Beuth J MMW Fortschr Med; 2000 Mar; 142(9):14. PubMed ID: 10795476 [No Abstract] [Full Text] [Related]
24. [Old and approved: phenosol therapy of arthrosis deformans]. Weidner K Landarzt; 1967 Jan; 43(3):120. PubMed ID: 6041457 [No Abstract] [Full Text] [Related]
28. [Analysis of major antigenic determinants in Mistletoe lectin I]. Maliuchenko NV; Moĭsenovich MM; Egorova SG; Gusarova VIu; Agapov II; Balashova TA; Tonevitskiĭ AG Biofizika; 1999; 44(6):1017-21. PubMed ID: 10707276 [TBL] [Abstract][Full Text] [Related]
29. Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research. Mengs U; Göthel D; Leng-Peschlow E Anticancer Res; 2002; 22(3):1399-407. PubMed ID: 12168816 [TBL] [Abstract][Full Text] [Related]
30. Intracellular expression of IL-4 and inhibition of IFN-gamma by extracts from European mistletoe is related to induction of apoptosis. Stein GM; Pfüller U; Schietzel M; Büssing A Anticancer Res; 2000; 20(5A):2987-94. PubMed ID: 11062712 [TBL] [Abstract][Full Text] [Related]
31. Comparison of the effects of various clinically applied mistletoe preparations on peripheral blood leukocytes. Elsässer-Beile U; Lusebrink S; Grussenmeyer T; Wetterauer U; Schultze-Seemann W Arzneimittelforschung; 1998 Dec; 48(12):1185-9. PubMed ID: 9893935 [TBL] [Abstract][Full Text] [Related]
32. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency. Galanina OE; Kaltner H; Khraltsova LS; Bovin NV; Gabius HJ J Mol Recognit; 1997; 10(3):139-47. PubMed ID: 9408830 [TBL] [Abstract][Full Text] [Related]
33. Characterisation of immunological reactivity of patients with adverse effects during therapy with an aqueous mistletoe extract. Stein GM; Berg PA Eur J Med Res; 1999 May; 4(5):169-77. PubMed ID: 10336405 [TBL] [Abstract][Full Text] [Related]
34. The identification and isolation of hypotensive and hypertensive principles in Phorodendron rubrum var. gracile--a West Indian medicinal plant. Ellington EV West Indian Med J; 1968 Sep; 17(3):155-7. PubMed ID: 5732758 [No Abstract] [Full Text] [Related]
35. Viscotoxin-free aqueous extracts from European mistletoe (Viscum album L.) stimulate activity of human granulocytes. Stein GM; Pfüller U; Schietzel M Anticancer Res; 1999; 19(4B):2925-8. PubMed ID: 10652574 [TBL] [Abstract][Full Text] [Related]
36. Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract. Heiny BM; Albrecht V; Beuth J Anticancer Res; 1998; 18(1B):583-6. PubMed ID: 9568181 [TBL] [Abstract][Full Text] [Related]